At the news
? NEUTRALIMPACT 3/10 144 filed Nov 2, 2026 at 16:40 ET
Director and officer Martine Rothblatt filed a Form 144 notice of intent to sell 119,410 shares of United Therapeutics common stock, with an estimated aggregate market value of approximately $71.5 million. The filing indicates these sales are part of a pre-arranged 10b5-1 trading plan, and Rothblatt has been executing daily sales of 9,500 shares since August 2026 under that plan.
- Martine Rothblatt, a director and officer of United Therapeutics, filed a Form 144 on 2026-11-02.
- The proposed sale covers 119,410 shares of common stock, with an estimated market value of $71,493,155.20.
- The filing explicitly references a 10b5-1 trading plan, with daily sales of 9,500 shares occurring since August 2026.
- Rothblatt has been executing these sales consistently from August through October 2026, with each day's sale valued between approximately $4.5M and $5.7M.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access